Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children
Magical thinking? FEM-PrEP trial may have failed because participants used testing as prevention
Malaysia’s harm reduction programmes are preventing infections and saving money, but reaching far too few people who inject drugs
Fibroscan accurately predicts liver decompensation and death in HIV/HCV co-infected people
Studies look at bone changes during second-line therapy, fractures, and HIV- and HCV-related bone loss
Southern African study shows tenofovir associated with lower risk of HBV resistance than 3TC among HIV-HBV-co-infected people starting antiretroviral therapy
Strategies to detect and treat MSM with acute infection may be a powerful tool to control HIV epidemics
Long-acting GSK1265744 and TMC278-LA appear safe and practical in early study
